7 September 2023
SHARE NOW
ATE
Cell Therapy
Finance & Investment
Gene Therapy
Regulatory & Standards
Reimbursement
Strategy
Miguel Forte, kicks off this panel session analyzing the retrospect of cell and gene therapy surrounding ideas of best practice, evidence generation for pricing, reimbursement and regulatory approval.
During this session, Miguel Forte, CEO, Kiji Therapeutics and President-Elect, ISCT is joined by Francis Pang, Senior Vice President, Global Market Access and International Geographic Expansion, Orchard Therapeutics, Mantej Chhina, Executive Director, Head of Global R&D Regulatory Policy, BioMarin and Julia Djonova, Head of the Advanced Therapy Medicinal Products, Swissmedic.
This Session was recorded at Advanced Therapies Europe 2023.
More like this
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
14 May 2024
Women in Advanced Therapies Global 2024, Virtual Event
Experience Women in Advanced Therapies Global, a 24-hour online event uniting the community in celebration of inspiration, innovation, and empowerment. Access exclusive insights, workshops, and networking opportunities from anywhere.
8 April 2024
